AstraZeneca PLC 是一家以科学为主导的生物制药公司。该公司专注于肿瘤学、罕见疾病和生物制药领域处方药的发现、开发和商业化,包括心血管、肾脏和代谢以及呼吸和免疫学。其管道在临床开发的各个阶段形成了强大的研究疗法组合。其产品线包括 Alexion Rare Disease产品组合,包括大约179个项目。其主要上市的肿瘤产品包括Tagrisso、Imfinzi、Lynparza、Calquence、Enhertu、Orpathys、Zoladex、Faslodex 等。其罕见病产品包括Soliris、Ultomiris、Strensiq和Kanuma。其生物制药产品包括Farxiga、Lokelma、Crestor、Breztri等。其地理区域包括英国、欧洲其他地区、美洲和亚洲、非洲和澳大拉西亚。该公司还专注于发现、开发和制造T细胞受体疗法。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| Michel Roger Demare | Independent Chairman | 2023 | 70 |
| Pascal Claude Roland Soriot | CEO & Executive Director | 2012 | 67 |
| Aradhana Sarin | CFO & Executive Director | 2021 | 52 |
| Pam P. Cheng | EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board | 2023 | 56 |
| Jeffrey Pott | CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board | 2023 | - |
| Philip Arthur John Broadley | Senior Independent Non-Executive Director | 2021 | 65 |
| Sabera Nazneen Rahman | Independent Non-Executive Director | 2017 | 59 |
| Sherilyn S. Dawn McCoy | Independent Non-Executive Director | 2017 | 68 |
| Marcus Wallenberg | Non-Executive Director | 1999 | 70 |
| Shu Kam Mok | Independent Non-Executive Director | 2019 | 66 |
| Euan Angus Ashley | Independent Non-Executive Director | 2020 | 55 |
| Diana Louise Patricia Layfield | Independent Non-Executive Director | 2020 | 56 |
| Pankaj Bhatia | Member of External Sustainability Advisory Board | - | - |
| Dame Veronica Anne Courtice | Member of External Sustainability Advisory Board | - | 74 |
| Louise Nicholls | Member of External Sustainability Advisory Board | - | - |
| Rain Henderson | Member of External Sustainability Advisory Board | - | - |
| Anna Olive Magdelene Manz | Non-Executive Director | 2023 | 53 |
| Rene Anthony Andrada Haas | Non-Executive Director | 2025 | 64 |
| Birgit M. Conix | Non-Executive Director | 2025 | 61 |
| Karen Elizabeth Knudsen | Non-Executive Director | 2025 | 56 |